Sonpavde G - Search Results

1

Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.

Nam HY, Chandrashekar DS, Kundu A, Shelar S, Kho EY, Sonpavde G, Naik G, Ghatalia P, Livi CB, Varambally S, Sudarshan S. Nam HY, et al. Among authors: sonpavde g. Mol Cancer Res. 2019 Jan;17(1):84-96. doi: 10.1158/1541-7786.MCR-17-0636. Epub 2018 Aug 21. Mol Cancer Res. 2019. PMID: 30131446 Free PMC article.

2

Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP. Shen SS, et al. Among authors: sonpavde g. Cancer. 2006 Jun 15;106(12):2610-6. doi: 10.1002/cncr.21945. Cancer. 2006. PMID: 16700038 Free article.

3

Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy.

Small AC, Tsao CK, Moshier EL, Gartrell BA, Wisnivesky JP, Godbold JH, Smith CB, Sonpavde G, Oh WK, Galsky MD. Small AC, et al. Among authors: sonpavde g. Cancer. 2012 Dec 1;118(23):5947-54. doi: 10.1002/cncr.27658. Epub 2012 Jun 15. Cancer. 2012. PMID: 22707387 Free article.

4

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma.

Sonpavde G, Choueiri TK. Sonpavde G, et al. Br J Cancer. 2012 Sep 25;107(7):1009-16. doi: 10.1038/bjc.2012.399. Epub 2012 Sep 4. Br J Cancer. 2012. PMID: 22948724 Free PMC article. Review.

5

Do the sites of metastases provide additional information regarding prognosis and biology in renal cell carcinoma?

Sonpavde G, Sudarshan S, Escudier B. Sonpavde G, et al. Eur Urol. 2014 Mar;65(3):585-6. doi: 10.1016/j.eururo.2013.09.001. Epub 2013 Sep 9. Eur Urol. 2014. PMID: 24044979 No abstract available.

6

Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma.

Sonpavde G, Willey CD, Sudarshan S. Sonpavde G, et al. Expert Opin Investig Drugs. 2014 Mar;23(3):305-15. doi: 10.1517/13543784.2014.871259. Epub 2014 Jan 3. Expert Opin Investig Drugs. 2014. PMID: 24387233 Review.

7

Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials.

Morgan CJ, Oh WK, Naik G, Galsky MD, Sonpavde G. Morgan CJ, et al. Among authors: sonpavde g. Crit Rev Oncol Hematol. 2014 Jun;90(3):253-61. doi: 10.1016/j.critrevonc.2013.12.001. Epub 2014 Feb 2. Crit Rev Oncol Hematol. 2014. PMID: 24500033 Review.

8

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Ghatalia P, Je Y, Kaymakcalan MD, Sonpavde G, Choueiri TK. Ghatalia P, et al. Among authors: sonpavde g. Br J Cancer. 2015 Jan 20;112(2):296-305. doi: 10.1038/bjc.2014.564. Epub 2014 Nov 6. Br J Cancer. 2015. PMID: 25349964 Free PMC article.

9

Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials.

Ghatalia P, Je Y, Mouallem NE, Nguyen PL, Trinh QD, Sonpavde G, Choueiri TK. Ghatalia P, et al. Among authors: sonpavde g. Crit Rev Oncol Hematol. 2015 Mar;93(3):257-76. doi: 10.1016/j.critrevonc.2014.11.006. Epub 2014 Nov 27. Crit Rev Oncol Hematol. 2015. PMID: 25523486 Review.

10

Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis.

Rocha P, Morgan CJ, Templeton AJ, Pond GR, Naik G, Sonpavde G. Rocha P, et al. Among authors: sonpavde g. Oncol Res Treat. 2014;37(12):772-6. doi: 10.1159/000369545. Epub 2014 Nov 20. Oncol Res Treat. 2014. PMID: 25531724 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters